5-HT1B and 5-HT1D receptors — Drug Target

All drugs that target 5-HT1B and 5-HT1D receptors — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Triptan (5-HT1B/1D receptor agonist) · Triptan

Marketed (1)

• Imitrex® · Teva Pharmaceuticals USA · Triptan (5-HT1B/1D receptor agonist) · Neurology
  Imitrex is a selective serotonin 5-HT1B/1D receptor agonist that constricts cranial blood vessels and inhibits neuropeptide release to relieve migraine headaches.

Phase 2 pipeline (1)

• Exposure to Triptan · Assistance Publique Hopitaux De Marseille · Triptan · Neurology
  Triptans are a class of drugs that work by stimulating serotonin receptors in the brain, leading to the dilation of blood vessels and the relief of migraine symptoms.